Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
POSA74 Accounting for Population Heterogeneity Over-Time in Estimating Costs and Outcomes in Cohort-Based Health-Economic EvaluationsFelizzi, F ; Manevy, F ; Di Maio, DValue in health, 2022-01, Vol.25 (1), p.S47-S48 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Potential non-drug cost differences associated with the use of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) in the treatment of HER2-positive early breast cancer patients in Western Europe and the United StatesManevy, Federico ; Filkauskas, Gabriele ; Levy, Pierre ; Fredriksson, Judy ; Sussell, JesseJournal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.544-544 [Periódico revisado por pares]Texto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Genetic structure characterization of Chileans reflects historical immigration patternsEyheramendy, Susana ; Martinez, Felipe I ; Manevy, Federico ; Vial, Cecilia ; Repetto, Gabriela MNature communications, 2015-03, Vol.6 (1), p.6472-6472, Article 6472 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an ExampleJackisch, Christian ; Manevy, Federico ; Frank, Suzanne ; Roberts, Nicki ; Shafrin, JasonAdvances in therapy, 2022-02, Vol.39 (2), p.833-844 [Periódico revisado por pares]Cheshire: Springer HealthcareTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact AnalysisBellone, M ; Pradelli, L ; Sanfilippo, A ; Caputo, A ; Manevy, F ; Zerilli, AValue in health, 2022-01, Vol.25 (1), p.S109-S109 [Periódico revisado por pares]Elsevier IncTexto completo disponível |